Searching: /health/

News

1.

independent.co.uk > news > health > coffee-chronic-pain-study-b2879657.html

The surprising link between your morning coffee and chronic pain

4+ min ago (431+ words) Eating more oily fish could conversely help reduce pain, according to the study Starting the morning with a cup of coffee is an essential for many Brits. But new research has suggested that while it might help kickstart your day, it could also be worsening chronic pain. A study by academics at Nicolaus Copernicus university in Poland has linked greater coffee consumption to higher pain levels in older adults. The research, which surveyed 205 healthy adults aged between 60 and 88 across two years, asked participants to track their fish and coffee intakes and pain levels using a ten-point scale. Scientists found an increased coffee intake was linked to a 6.56-point rise in pain intensity when compared with those who decreased their coffee intake. However, an increased oily fish intake was associated with a 4.45-point reduction in pain intensity. Researchers said this may…...

2.

statnews.com > 12/07/2025 > incyte-results-myelofibrosis-treatment-ash-2025

Incyte study results suggest a new approach to treating myelofibrosis

15+ min ago (289+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the weekly newsletter Adam's Biotech Scorecard. In 2022, a series of stories by Feuerstein and STAT colleagues that examined Biogen and the controversial approval of its Alzheimer's disease drug Aduhelm won the George Polk Award for medical reporting, and NIHCM and SABEW journalism prizes. Prior to joining STAT in 2017, Feuerstein was a longtime biotech reporter at TheStreet, a biotech analyst for a New York investment fund, and covered the early internet and dot-com era as a San Francisco-based technology reporter. You can reach Adam on Signal at stataf.54. Incyte study results suggest a new approach to treating myelofibrosis The biotech is hunting…...

3.

deccanchronicle.com > southern-states > telangana > doctors-report-widespread-measles-spike-seek-urgent-public-health-intervention-1922368

Doctors Report Widespread Measles Spike, Seek Urgent Public Health Intervention

19+ min ago (539+ words) Hyderabad: Measles cases are not yet a trend in government hospitals, but private paediatricians in Hyderabad are reporting a rise in infections. The need for an official dashboard showing the number of tests conducted, positivity rates, and an advisory to parents from the Directorate of Public Health has become urgent. Deccan Chronicle approached health authorities for official figures, but officials said they need more time as they are occupied with preparations for the Telangana Rising Global Summit. Dr G. Vijay Kumar from Niloufer Hospital said there is no need to create panic. "We are seeing cases with fever and rash, and we are conducting tests," he said. Hyderabad district medical and health officer Dr J. Venkati also confirmed that measles cases are being detected in the city. Hyderabad district immunisation officer Dr Puppala Sridhar said teams were being alerted about suspected fever-and-rash…...

4.

the-sun.com-sun.com

Eric Dane gives heartbreaking health update amid ALS diagnosis & reveals future

20+ min ago (694+ words) In an emotional interview he said he is fighting as much as he can ERIC Dane has given a heart-breaking health update amid his ALS diagnosis and revealed his TV future. The Grey's Anatomy alum, 53, first announced his battle with amyotrophic lateral sclerosis, otherwise known as ALS, in April. Eric appeared on a virtual panel for IAMALS.org last week where he admitted how he felt about his brutal diagnosis. He has lost mobility in his arms, has changes to his speech, and uses a wheelchair, due to the disease which affects nerve cells in the brain and spinal cord. An emotional Eric explained: "I have no reason to be in a good spirit at any time, on any given day. "I don't think anybody would blame me if I went upstairs in my bedroom, crawled under the sheets, and…...

5.

news18.com > agency-feeds > air-ambulance-for-bangladeshs-ex-pm-khaleda-zia-to-land-in-dhaka-on-tuesday-9755970.html

Air ambulance for Bangladesh's ex-PM Khaleda Zia to land in Dhaka on Tuesday

28+ min ago (316+ words) Dhaka, Dec 7 (PTI) An air ambulance arranged to fly Bangladesh's critically ill former prime minister Khaleda Zia to London for medical treatment will land in Dhaka on Tuesday, aviation officials said on Sunday. A senior official at the Civil Aviation Authority of Bangladesh (CAAB) said the aircraft has been allotted an 8 am landing slot on Tuesday, with a departure time of 9 pm the same day, news portal bdnews24.com reported. According to tbsnews.net, the Qatar government has arranged the aircraft, renting it from the Germany-based FAI Aviation Group after opting for a replacement air ambulance to conduct the long-range medical evacuation. FAI Aviation Group's initial application had sought clearance to land on Tuesday and depart for London on Wednesday. Zia, the 80-year-old Bangladesh Nationalist Party (BNP) chairperson, has been receiving treatment for multiple ailments at Dhaka-based Evercare Hospital for nearly…...

6.

stocktitan.net > news > INCY > incyte-s-first-in-class-mut-calr-targeted-monoclonal-antibody-qqxr7s5n3k7a.html

Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA

28+ min ago (499+ words) Incyte (Nasdaq:INCY) announced the U.S. FDA granted Breakthrough Therapy designation to INCA033989, a first'in'class mutCALR'targeted monoclonal antibody, for treatment of essential thrombocythemia (ET) patients with a Type 1 CALR mutation who are resistant or intolerant to at least one cytoreductive therapy.The designation was supported by early Phase 1 data showing INCA033989 was well'tolerated and produced rapid, durable platelet normalization; updated Phase 1 data and new myelofibrosis results will be presented at ASH 2025 on December 8. Incyte plans to seek regulator alignment and begin a Phase 3 program in mid'2026 to evaluate patients with all CALR mutation types.Key context: CALR mutations occur in ~25% of ET patients and Type 1 deletions represent ~55% of CALR mutations....

7.

stocktitan.net > news > RIGL > rigel-presents-updated-data-from-the-ongoing-phase-1b-study-p5r8jux4z6ge.html

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition

28+ min ago (401+ words) R289 continues to be generally well tolerated and at doses of" 500 mg QD preliminary efficacy was observed in elderly, heavily pre-treated lower-risk MDS patients RBC-TI was achieved by 33% of evaluable transfusion dependent patients receiving R289 doses" 500 mg QD, including 40% in the 500 mg BID dose group. SOUTH SAN FRANCISCO, Calif., Dec. 7, 2025/ PRNewswire/--......

8.

finance.yahoo.com > news > incyte-first-class-mutcalr-targeted-143000438.html

Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA

28+ min ago (231+ words) The Company plans to initiate a Phase 3 program evaluating INCA033989 in essential thrombocythemia (ET) patients with all types of CALR mutations in mid-2026, following alignment with regulators Updated safety and efficacy data for INCA033989 in ET, and new data in myelofibrosis (MF), will be presented at the upcoming 2025 ASH Annual Meeting The FDA Breakthrough Therapy Designation was supported by the early Phase 1 data evaluating INCA033989 in ET patients with a Type 1 CALR mutation available at the time of submission. Incyte plans to develop INCA033989 for patients with Type 1 and non-Type 1 CALR mutations and, following discussions with regulatory agencies, plans to initiate a registrational program evaluating patients with ET with a Type 1 or non-Type 1 CALR mutation who are resistant or intolerant to at least one cytoreductive therapy in the first half of next year. About Essential ThrombocythemiaEssential thrombocythemia (ET) is a chronic myeloproliferative neoplasm (MPN) characterized…...

9.

independent.co.uk > life-style > health-and-families > skin-cancer-symptoms-vitamin-b3-b2879676.html

The cheap vitamin that could prevent the most frequently diagnosed cancer

30+ min ago (722+ words) New research suggests that adding this pill to daily routines could dramatically lower skin cancer risk A major shift is unfolding in the field of skin cancer prevention, ignited by new research showing that an everyday vitamin supplement may prevent many cases of the world's most frequently diagnosed cancer. The supplement in question is nicotinamide, a form of vitamin B3. Whereas previous studies hinted at a potential benefit, the latest research " spanning more than 33,000 US veterans " suggests that adding this simple vitamin pill to daily routines could dramatically lower skin cancer risk, especially for those who have already experienced their first case. The scale, breadth and clarity of this evidence are driving calls to rethink how skin cancer is prevented. Skin cancer is the world's most common form of cancer. Non-melanoma types, including basal cell carcinoma and cutaneous squamous cell carcinoma,…...

10.

menafn.com > 11/10/448613 > Odisha-CM-Majhi-Praises-100-Year-Old-K-Lakshmi-Bai-For-Her-Selfless-Contribution-To-Healthcare

Odisha CM Majhi Praises 100-Year-Old K. Lakshmi Bai For Her Selfless Contribution To Healthcare

34+ min ago (337+ words) CM Majhi called her donation an inspiring act of strong humanitarian values and devotion towards public service. Taking to his official X account, the Chief Minister wrote, "I got to know about K. Lakshmi Bai Ji's extraordinary gesture on the occasion of her 100th birthday. Donating her personal savings to establish a gynaecological oncology course at AIIMS Bhubaneswar is an inspiring act of deep compassion and public service." He also noted that her decades-long medical service is an inspiration for all. "A true torch-bearer of dignity, care, and women's empowerment, her decades of dedicated medical service continue to inspire generations. People like her strengthen our collective resolve to build a healthier, more empowered society," CM Majhi said. He emphasised that the state government remains committed to advancing quality healthcare for all. "Odisha takes immense pride in her remarkable life and her selfless…...